1-877-936-8422

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

VUMC to help engage more study participants in research decisions

Submitted by sobecksm on

Human research will be more equitable, inclusive and stronger if the people who are participants in studies also help plan and guide the direction of those studies.

https://news.vumc.org/2023/10/25/vumc-to-help-engage-more-study-participants-in-research-decisions/
Bill Snyder
Locked

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Lung

The study is intended to assess the safety and efficacy of perioperative treatment with
Durvalumab in combination with Oleclumab, Monalizumab or AZD0171 and platinum doublet
chemotherapy; or MEDI5752 in combination with platinum doublet chemotherapy or datopotamab
deruxtecan (Dato-DXd) in combination with durvalumab and single agent platinum chemotherapy
in participants with resectable, early-stage non-small cell lung cancer.
Lung
II
Lovly, Christine
NCT05061550
VICCTHO2292
Learn More

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.

Call Now
NCI Designated Cancer Center
NCCN National Comprehensive Cancer Network
NCI National Clinical Trials Network